News

No benefits to helmet therapy for positional skull deformation


 

FROM BMJ

Researchers have discouraged the use of helmet therapy in infants with positional skull deformation after a single-blinded, randomized controlled trial showed no advantages over allowing the generally cosmetic condition to run its natural course.

The Dutch study found no differences in the change score at 2 years of age for both plagiocephaly and brachycephaly in 84 infants randomized either to 6 months of helmet therapy or to the natural course of the condition, according to a study published May 1 in BMJ (2014;348:g2741 [doi: 10.1136/bmj.g2741]).

©area73/thinkstockphotos.com

Only a quarter of helmet-treated infants had a full recovery, casting doubts over the effectiveness of the therapy.

Detailed measurements of each child’s head were done at age 2 years. Just more than a quarter (26%) of children who had helmet therapy experienced a full recovery at that time, compared with 23% of those who did not use a helmet. The difference was not significant.

All parents in the helmet therapy group reported one or more side effects, the most common being problems with acceptance of the helmet, skin irritation, augmented sweating, unpleasant odor of the helmet, pain associated with the helmet, and feeling hindered from cuddling their child.

However, those parents also showed slightly higher satisfaction scores and a slightly lower anxiety state when their infants were 2 years old.

The study was funded by a grant from ZonMw, the Netherlands Organization for Health Research and Development. No other conflicts of interest were declared.

Recommended Reading

Hemangeol approved for treatment of infantile hemangioma
MDedge Family Medicine
FDA proposes to regulate e-cigarettes, cigars
MDedge Family Medicine
CDC: Vaccines prevent millions of illnesses, but measles makes a return
MDedge Family Medicine
AACAP disagrees with marijuana legalization, cites harmful effects on children
MDedge Family Medicine
Suicide doubles in young patients starting high-dose SSRIs
MDedge Family Medicine
How often does otitis media cause fever?
MDedge Family Medicine
Approval of mercaptopurine suspension will facilitate pediatric dosing
MDedge Family Medicine
AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics
MDedge Family Medicine
Young children with OCD respond to family-based therapy
MDedge Family Medicine
Studies hint at safety, efficacy of spinal muscular atrophy drug
MDedge Family Medicine